# Effects of N-acetyl Cysteine During Primary Percutaneous Coronary Intervention

Study · id `cardio:ct-nct01878344` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01878344](<https://clinicaltrials.gov/study/NCT01878344>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01878344

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 100 participants.

## Technical summary

Registry record NCT01878344. Randomized; triple masking; primary purpose diagnostic. Start 2013-01 (actual); primary completion 2018-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose diagnostic
- Phase: Phase 3
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT01878344, source copy `cardio:ctgov-nct01878344-2025-05-20`, retrieved 2026-10-26)
- Started: 2013-01 (actual) (ClinicalTrials.gov record NCT01878344, source copy `cardio:ctgov-nct01878344-2025-05-20`, retrieved 2026-10-26)
- Primary completion: 2018-01 (actual) (ClinicalTrials.gov record NCT01878344, source copy `cardio:ctgov-nct01878344-2025-05-20`, retrieved 2026-10-26)
- Completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT01878344, source copy `cardio:ctgov-nct01878344-2025-05-20`, retrieved 2026-10-26)
- Countries: Türkiye (ClinicalTrials.gov record NCT01878344, source copy `cardio:ctgov-nct01878344-2025-05-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01878344-2025-05-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effects of N-acetyl Cysteine During Primary Percutaneous Coronary Intervention
- Acronym: EASE-PRM-PCI
- Condition: Acute ST Segment Elevation Myocardial Infarction
- Intervention (Drug): NAC
- Intervention (Drug): Saline
- Lead sponsor: Suleyman Demirel University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: Suleyman Demirel University (`cardio:org-suleyman-demirel-university`)

## Provenance

Content hash: ed1e422adfbffbeaca2a0519b4b5f22849e4773824a49a3fca65b550e02f5454
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
